Search research articles
Contact Us
Filters
Showing results (321-330 of 371) with videos related to
Page
of 38
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 16, 2013
Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group
Andreas du Bois, Nina Ewald-Riegler, Nikolaus de Gregorio, et al.
Breast Care (Basel, Switzerland)
|
January 14, 2014
13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013)
Michael Untch, Bernd Gerber, Nadia Harbeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2025
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial
Philipp Harter, Frederik Marmé, Andrés Redondo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2025
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer
Fabio Conforti, Valentina Nekljudova, Isabella Sala, et al.
Geburtshilfe Und Frauenheilkunde
|
November 5, 2019
Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)
Hans-Georg Schnürch, Sven Ackermann, Celine D Alt-Radtke, et al.
International Journal of Cancer
|
July 15, 2018
Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)
Kiki C Andree, Anouk Mentink, Leonie L Zeune, et al.
Breast Cancer Research and Treatment
|
September 26, 2014
Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies
Jessica Salmen, Julia Neugebauer, Peter A Fasching, et al.
Oncotarget
|
November 28, 2018
EpCAM<sup>high</sup> and EpCAM<sup>low</sup> circulating tumor cells in metastatic prostate and breast cancer patients
Sanne de Wit, Mariangela Manicone, Elisabetta Rossi, et al.
The Lancet. Oncology
|
November 27, 2025
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials
Fabio Conforti, Johannes Holtschmidt, Valentina Nekljudova, et al.
Cancers
|
July 20, 2021
Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance
Heike Hoyer, Grit Mehlhorn, Cornelia Scheungraber, et al.
Page
of 38
Search research articles
Search
Showing results (321-330 of 371) with videos related to
Sort By:
Page
of 38
European Journal of Cancer (Oxford, England : 1990)
|
March 16, 2013
Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group
Andreas du Bois, Nina Ewald-Riegler, Nikolaus de Gregorio, et al.
Breast Care (Basel, Switzerland)
|
January 14, 2014
13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013)
Michael Untch, Bernd Gerber, Nadia Harbeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2025
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial
Philipp Harter, Frederik Marmé, Andrés Redondo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2025
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer
Fabio Conforti, Valentina Nekljudova, Isabella Sala, et al.
Geburtshilfe Und Frauenheilkunde
|
November 5, 2019
Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)
Hans-Georg Schnürch, Sven Ackermann, Celine D Alt-Radtke, et al.
International Journal of Cancer
|
July 15, 2018
Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)
Kiki C Andree, Anouk Mentink, Leonie L Zeune, et al.
Breast Cancer Research and Treatment
|
September 26, 2014
Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies
Jessica Salmen, Julia Neugebauer, Peter A Fasching, et al.
Oncotarget
|
November 28, 2018
EpCAM<sup>high</sup> and EpCAM<sup>low</sup> circulating tumor cells in metastatic prostate and breast cancer patients
Sanne de Wit, Mariangela Manicone, Elisabetta Rossi, et al.
The Lancet. Oncology
|
November 27, 2025
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials
Fabio Conforti, Johannes Holtschmidt, Valentina Nekljudova, et al.
Cancers
|
July 20, 2021
Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance
Heike Hoyer, Grit Mehlhorn, Cornelia Scheungraber, et al.
Page
of 38